A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

September 21, 2026

Study Completion Date

September 5, 2028

Conditions
Dwarfism, Pituitary
Interventions
DRUG

Somatrogon

Long-acting growth hormone for pediatric growth hormone deficiency.

Trial Locations (3)

600006

RECRUITING

Apollo Children's Hospital, Chennai

625020

RECRUITING

Apollo Speciality Hospital, Madurai

641037

RECRUITING

G Kuppuswamy Naidu Memorial Hospital, Coimbatore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06587035 - A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India. | Biotech Hunter | Biotech Hunter